Senores Pharmaceuticals Limited IPO Allotment Status: Check Allotment Status Online on BSE, NSE & Link Intime India

Use of Proceeds

The company intends to utilize the net proceeds from the offering for several purposes, including investing in its subsidiary, Havix Group, Inc. (d/b/a Aavis Pharmaceuticals), to support capital expenditure for setting up a manufacturing facility for sterile injections at the Atlanta Facility. Additionally, the proceeds will be used to repay or prepay, in full or in part, certain borrowings incurred by the company. The company also plans to invest in Havix to help the subsidiary repay or prepay its own borrowings. A portion of the funds will be allocated to meet the company’s working capital needs, as well as those of its subsidiaries, Senores Pharmaceuticals Inc. (SPI) and Ratnatris Pharmaceutical Private Limited (Ratnatris). The remaining funds will be used to support inorganic growth through acquisitions, strategic initiatives, and general corporate purposes.

Checking the Allotment Status

Steps to Check Allotment Status on BSE 

1. Visit the IPO allotment page on the BSE website here.  
2. Select the issue type as 'Equity.'  
3. Select 'Senores Pharmaceuticals Limited' from the dropdown menu.  
4. Enter your application number or PAN (Permanent Account Number).  
5. Clear the 'Captcha' to verify that you are not a robot. 
6. Click on the 'Search' option to see your allotment status.

Steps to Check Allotment Status on NSE

1. Visit NSE’s IPO bid verification page here.
2. Register on the website if you are a new user.
3. Select ‘Senores Pharmaceuticals Limited’.
4. Enter details such as your application number.
5. Click on ‘Get Data’.

Steps to Check Allotment Status on Link Intime India

1. Visit the Link Intime website here.
2. From the list of available IPOs, select ‘Senores Pharmaceuticals Limited’.
3. You may be required to select one of the four modes: application number, DP /Client ID, PAN, or Account number/IFSC.
4. Click on "Submit" to view your allotment status.

Senores Hospitality Business Overview

Senores Pharmaceuticals Limited, founded in December 2017, focuses on developing and manufacturing pharmaceutical products for both regulated and emerging markets, with a primary emphasis on the US, Canada, and the UK. 

By September 2024, Senores Pharmaceuticals had launched 55 products across various therapeutic categories and established partnerships with distributors and hospitals throughout India. The company is also expanding its presence in 43 emerging markets, with a focus on manufacturing critical care injectables and active pharmaceutical ingredients (APIs).

The company operates three R&D facilities in India and the US and has a manufacturing unit in Ahmedabad, Gujarat, which supports its production capacity.

Senores Pharmaceuticals IPO Day 3 Subscription Status 

(December 24, 2024, End of Day)

By the third day of bidding, the Senores Pharmaceuticals Limited had been subscribed 93.69 times the total number of shares available. The Non-Institutional Investors (NIIs) segment subscribed 96.30 times their allotted portion, while the Retail Investors segment subscribed 90.46 times the shares reserved for them. The Qualified Institutional Buyers (QIBs) category recorded a subscription of 94.66 times, and the Employees category saw a subscription of 20.21 times.